| abstract |
Antibodies that bind CSF1R are provided. Antibody heavy chains and light chains that are ncapable of forming antibodies that bind CSF1R are also provided. Polynucleotides encoding nantibodies to CSF1R are provided. Polynucleotides encoding antibody heavy chains and nlight chains are also provided. Methods of treatment using antibodies to CSF1R are nprovided. Such methods include, but are not limited to, methods of treating rheumatoid narthritis, bone loss, and multiple sclerosis. n11010623_1 (GHMatters) P91639.AU.3 |